“We are thrilled to welcome Laura to the Character team, and to tap into her strategic vision and strong history of developing innovative therapeutics,” said Cheng Zhang, Co-Founder and Chief Executive Officer of Character Biosciences. “Laura’s deep experience will prove invaluable as we progress our lead drug candidates into the clinic for dry Age-related Macular Degeneration, an area of significant unmet need, and expand our therapeutic pipeline leveraging proprietary insights into disease progression.”

https://www.businesswire.com/news/home/20230913866611/en/Character-Biosciences-Strengthens-Leadership-Team-with-Appointment-of-Laura-Carter-Ph.D.-as-Chief-Scientific-Officer